|Day's Range||41.30 - 41.38|
|52 Week Range||32.53 - 42.02|
|PE Ratio (TTM)||30.88|
|Dividend & Yield||0.44 (1.06%)|
|1y Target Est||28.00|
Categories: Yahoo FinanceGet free summary analysis Merck KGaA reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Merck KGaA – Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., Abbott Laboratories, Amgen Inc. and Biogen Inc. (BMY-US, PFE-US, MRK-US, ABT-US, AMGN-US and BIIB-US) that have also ... Read more (Read more...)
The Soros Fund appears to be testing the waters with Pfizer.
Merck, a leading science and technology company, convened experts from diverse reputable organizations such as UN, UNICEF, UNAIDS, World Obesity Federation and McKinsey at the company's headquarters in Darmstadt, Germany, to debate relevant questions such as: What are the most urgent threats to our children's long-term health? What can be done both inside and outside the classroom?